Rodent Models of Global Cerebral Ischemia

Michael J. O'Neill1, James A. Clemens2

1 Eli Lilly and Co., Windlesham, Surrey, United Kingdom, 2 Lilly Corporate Center, Indianapolis, Indiana
Publication Name:  Current Protocols in Neuroscience
Unit Number:  Unit 9.5
DOI:  10.1002/0471142301.ns0905s12
Online Posting Date:  May, 2001
GO TO THE FULL TEXT: PDF or HTML at Wiley Online Library

Abstract

Brain damage after stroke and head injury remains a huge clinical problem. In stroke, the initial cause of the damage is a blockage in a blood vessel (often the middle cerebral artery) and this sets off several pathways that ultimately lead to cell death. Recent studies have demonstrated that several new mechanisms are involved in neuronal death and this has led to an increase in research into novel molecules that might prevent brain damage or improve recuperation post‐stroke. There are several models of global cerebral ischemia. Two of the most widely‐used models are discussed in detail in UNIT, the gerbil bilateral carotid artery occlusion (BCAO) model and rat 4‐vessel occlusion (4‐VO) model. Additionally, several models of focal cerebral ischemia have been developed to mimic the effects of human stroke. The rationale behind the use of animal models, the various types of models and advantage and disadvantages of each model are presented.

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Table of Contents

  • Why Use Animal Models?
  • Basic Protocol 1: Gerbil Bilateral Carotid Artery Occlusion (BCAO) Model to Test Systemically Active Neuroprotective Agents
  • Alternate Protocol 1: Gerbil BCAO Model to Test Neuroprotective Agents that Do Not Penetrate the Brain
  • Alternate Protocol 2: Gerbil BCAO to Induce Ischemic Tolerance
  • Basic Protocol 2: Use of 4‐Vessel Occlusion (4‐VO) Model to Study Neuronal Degeneration and Test the Effects of Neuroprotective Agents Against Global Cerebral Ischemia
  • Support Protocol 1: Hematoxylin and Eosin Staining of Brain Tissue
  • Support Protocol 2: Measurement of Locomotor Activity After Ischemia in Gerbils
  • Support Protocol 3: Fabrication of Atraumatic Clasps for Rat 4‐VO
  • Reagents and Solutions
  • Commentary
  • Literature Cited
  • Figures
  • Tables
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Materials

Basic Protocol 1: Gerbil Bilateral Carotid Artery Occlusion (BCAO) Model to Test Systemically Active Neuroprotective Agents

  Materials
  • Male Mongolian gerbils, 60 to 80 g (Bantin and Kingman)
  • Test compounds
  • Inhalational anesthetic (halothane or isoflurane)
  • Saline: 0.9% NaCl
  • 10% buffered formalin (see recipe)
  • Pentobarbital or chloral hydrate
  • 60%, 80%, and 90% industrial methylated spirits (IMS; e.g., Fisher) in distilled H 2O
  • Syringes and needles suitable for route of compound administration (e.g., intramuscular, intravenous, or oral)
  • Inhalation anesthetic apparatus comprising, e.g., oxygen, vaporizer, tubing, and vacuum trap (International Market Supply)
  • Heating pad/blanket
  • Rectal temperature monitor (RS Components)
  • Electric hair clippers
  • Methiolate tincture (Lilly)
  • Fiber optic light source
  • Surgical instruments: including scissors, scalpel, and forceps (e.g., John Weiss & Sons)
  • Vascular clamps (Holborn Surgical Instruments)
  • Silk thread (6/6 braided suture; International Market Supply)
  • Suture (Ethicon W529 6/0 Mersilk; A.C. Daniels)
  • Thermacages (Beta Medical & Scientific) or thermostatically controlled incubators
  • Dram vials, glass scintillation vials, or similar glass vials
  • Rodent brain matrix, coronal gerbil (ASI Instruments)
  • Automated tissue processor (e.g., Tissue‐Tek VIP 2000 vacuum infiltrator processor; Miles Scientific or Bayer Diagnostics)
  • Sledge microtome (Leitz 1400)
  • Additional reagents and equipment for hematoxylin/eosin staining of brain tissue (see protocol 5) and perfusion fixation (see unit 1.1)

Alternate Protocol 1: Gerbil BCAO Model to Test Neuroprotective Agents that Do Not Penetrate the Brain

  • Stereotaxic frame (e.g., model 900 from David Kopf Instruments or Bilaney Consultants)
  • 28‐G injection cannula (Plastics One)
  • Electrode holders/cannula holder (e.g., model 1770,1771 from David Kopf Intruments)
  • 25‐µl Hamilton syringe
  • Infusion pump (World Precision Instruments)
  • Anesthesia mask (David Kopf Instruments or Bilaney Consultants)
  • Fine‐tipped felt pen
  • Dental drill (Biotech Instruments) and 0.9‐mm steel drill bits/burrs (Interfocus Ltd.)

Alternate Protocol 2: Gerbil BCAO to Induce Ischemic Tolerance

  Materials
  • Male Wistar rats, 280 to 300 g
  • Isoflurane
  • Antiseptic solutions (e.g., Betadine and 70% ethanol)
  • Pentobarbital or chloral hydrate
  • 10% buffered formalin (see recipe)
  • Inhalation anesthetic apparatus suitable for use with isoflurane (Vetamac)
  • Stereotaxic frame (David Kopf Instruments)
  • Rat anesthesia mask (David Kopf Instruments)
  • Electric hair clippers
  • Surgical instruments including scissors, scalpel, forceps (Miltex Surgical Instruments)
  • Operating microscope
  • Electrocautery unit no. 160‐1370 (hand piece with electrocautery needle, 0.5 mm diameter; Tiemann & Co.)
  • Wound clips
  • Atraumatic carotid clasps (constructed according to protocol 7)
  • PE20 polyethylene tubing (Fisher)
  • Bulldog artery clamp, Johns Hopkins, straight, 1.5‐in. length (Roboz Surgical)
  • Rectal thermistor (Yellow Springs Instrument)
  • YSI Temperature Controller Model 73A (Yellow Springs Instrument)
  • Harvard Compact Infusion Pump Model 975 (Harvard Instruments)
  • Heat lamp (from local hardware store)
  • Physitemp temperature controller (Physitemp)
  • Physitemp type IT‐21 tissue implantable thermocouple (Physitemp)
  • Flow‐through swivel (Harvard Instrument)
  • Masterflex peristaltic pump (Cole Parmer)
  • Additional reagents and equipment for fixing and staining brain tissue (see protocol 1).

Basic Protocol 2: Use of 4‐Vessel Occlusion (4‐VO) Model to Study Neuronal Degeneration and Test the Effects of Neuroprotective Agents Against Global Cerebral Ischemia

  Materials
  • Slides of paraffin‐embedded brain tissue (see protocol 1)
  • Xylene (Fisher)
  • 70%, 75%, and 100% industrial methylated spirits (IMS; e.g., Fisher) in Coplin jars
  • Gill's hematoxylin (available as ready‐to‐use preparation from Surgipath)
  • 2% eosin (see recipe)
  • DPX mountant (BDH)
  • Coverslips
  • Slide trays

Support Protocol 1: Hematoxylin and Eosin Staining of Brain Tissue

  Materials
  • Automated locomotor activity apparatus (e.g., Greenacre; also see unit 8.1)
  • SAS Software for gathering and analyzing data (e.g., Misac Instruments)

Support Protocol 2: Measurement of Locomotor Activity After Ischemia in Gerbils

  Materials
  • White baby buttons (Blumenthal Industries)
  • Silastic tubing, 0.012 in. i.d. × 0.25 in. o.d. (Dow‐Corning)
  • PE90 polyethylene tubing (Fisher)
  • 5‐min epoxy glue (from local hardware store)
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Figures

Videos

Literature Cited

   Babcock, A.M., Baker, D.A., and Lovec, R. 1993. Locomotor activity in the ischemic gerbil. Brain Res 625:351‐354.
   Benham, C.D., Brown, T.H., Cooper, D.G., Evans, M.L., Harries, M.H., Herdon, H.J., Meakin, J.E., Murkitt, K.L., Patel, S.R., Roberts, J.C., Rothaul, A.H., Smith, S.J., Wood, N., and Hunter, A.J. 1993. SB201823‐A, a neuronal Ca2+ antagonist is neuroprotective in two models of cerebral ischaemia. Neuropharmacology 32:1249‐1257.
   Bentué‐Ferrer, D., Bellissant, E., Decombe, R., and Allain, H. 1994. Temporal profile of aminergic neurotransmitter release in striatal dialysates in rats with post‐ischemic seizures. Exp. Brain Res. 97:437‐443.
   Benveniste, H., Drejer, J., Schousboe, A., and Diemer, N.H. 1984. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1369‐1374.
   Bonita, R. 1992. Epidemiology of stroke. Lancet 339:342‐344.
   Boxer, P.A. and Bigge, C.F. 1997. Mechanisms of neuronal cell injury/death and targets for drug intervention. Drug Discovery Today 2:219‐228.
   Chandler, M.J., DeLeo, J., and Carney, J.M. 1985. An unanaesthetized gerbil model of cerebral ischemia‐induced behavioural changes. J. Pharmacol. Methods 14:137‐146.
   Clemens, J.A., Saunders, R.D., Ho, P.P., Phebus, L.A., and Panetta, J.A. 1993. The antioxidant LY231617 reduces global ischemic neuronal injury in rats. Stroke 24:716‐723.
   Clemens, J.A., Stephenson, D.T., Yin, T., Smalstig, E.B., Panetta, J.A., and Little, S.P. 1998. Drug‐induced neuroprotection from global ischemia is associated with prevention of persistent, but not transient activation of NF‐κB in rats. Stroke 29:677‐682.
   Combs, D.J. and D'Alecy, L.G. 1987. Motor performance in rats exposed to severe forebrain ischemia: Effect of fasting and 1,3‐butanediol. Stroke 18:503‐511.
   Corbett, D., Evans, S., Thomas, C., Wang, D., and Jones, R.A. 1990. MK‐801 reduced cerebral ischemic injury by inducing hypothermia. Brain Res 514:300‐304.
   Corbett, D., Evans, S., and Nurse, S. 1992. Impaired acquisition of Morris water maze following global ischemic damage in the gerbil. NeuroReport 3:204‐206.
   Del Zoppo, G.J., Wagner, S., and Tagaya, M. 1997. Trends and future develpoments in the pharmacological treatment of acute stroke. Drugs 54:9‐38.
   Dirnagel, U., Iadecola, C., and Moskowitz, M.A. 1999. Pathobiology of ischaemic stroke: An integrated view. Trends Neursosci. 22:391‐397.
   Donovan, J. and Brown, P. 1995. Parenteral injections. In Current Protocols in Immunology (J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober, eds.) pp. 1.6.1‐ 1.6.10. John Wiley & Sons, New York.
   Gill, R., Foster, A.C., and Woodruff, G.N. 1987. Systemic administration of MK‐801 protects against ischemia‐induced hippocampal neurodegeneration in the gerbil. J. Neurosci. 7:3343‐3349.
   Ginsberg, M.D. and Busto, R. 1989. Rodent models of cerebral ischemia. Stroke 20:1627‐1642.
   Green, D.R. and Reed, J.C. 1998. Mitochondria and apoptosis. Science 281:1309‐1312.
   Grotta, J.C., Pettigrew, L.C., Lockwood, A.H., and Reich, C. 1987. Brain extraction of a calcium channel blocker. Ann. Neurol. 21:171‐175.
   Hunter, A.J., Green, A.R., and Cross, A.J. 1995. Animal models of acute ischaemic stroke: Can they predict clinically successful neuroprotective drugs. Trends Pharmacol. Sci. 16:123‐128.
   Imamura, L., Ohta, H., Ni, X.‐H., Matsumoto, K., and Watanabe, H. 1991. Effects of transient cerebral ischemia in gerbils on working memory performance in delayed nonmatching to position task using T‐maze. Jpn. J. Pharmacol. 57:601‐608.
   Ito, U., Sportz, M., Walker, J.T., Jr., and Klato, I. 1975. Experimental cerebral ischemia in Mongolian gerbils. I. Light microscopic observations. Acta Neuropathol. 32:209‐223.
   Judge, M.E., Sheardown, M.J., Jacobsen, P., Honore, T. 1991. Protection against post‐ischemic behavioral pathology by the alpha‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid (AMPA) antagonist 2,3‐dihydroxy‐6‐nitro‐7‐sulfamoyl‐benzo(f)quinoxaline (NBQX) in the gerbil. Neurosci. Lett. 133:291‐294.
   Kahn, K. 1972. The natural course of experimental cerebral infarction in the gerbil. Neurology 22:510‐515.
   Katoh, A., Ishibashi, C., Shiomi, T., Takahara, Y., and Eigyo, M. 1992. Ischemia‐induced irreversible deficit of memory function in gerbils. Brain Res. 577:57‐63.
   Kawamata, T., Dietrich, W.D., Schallert, T., Gotts, J.E., Cocke, R.R., Benowitz, L.I., and Finklestein, S.P. 1997. Intracisternal basic fibroblast growth factor enhances functional recovery and up‐regulates the expression of a molecule marker of neuronal sprouting following focal cerebral infarction. Proc. Natl. Acad. Sci. U.S.A. 94:8179‐8184.
   Kawamata, T., Ren, J.‐M., Chan, T.C.K., Charette, M., and Finklestein, S.P. 1998. Intracisternal osteogenic protein‐1 enhances functional recovery following focal stroke. NeuroReport 9:1441‐1445.
   Kirino, T. 1982. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239:57‐69.
   Kirino, T. and Sano, K. 1984. Selective vulnerability in the gerbil hippocampus following transient ischemia. Acta Neuropathol. 62:201‐208.
   Kirino, T., Tamura, A., and Sano, K. 1985. Selective vulnerability of the hippocampus to ischemia‐reversible and irreversible types of ischemic cell damage. Prog. Brain Res. 63:39‐58.
   Kirino, T., Tamura, A., and Sano, K. 1986. A reversible type of neuronal injury following ischemia in the gerbil hippocampus. Stroke 17:455‐459.
   Kirino, T., Yoshihiko, T., and Tamura, A. 1991. Induced tolerance to ischemia in gerbil hippocampal neurons. J. Cereb. Blood Flow Pharmacol. Methods 11:299‐307.
   Kristian, T. and Siesjö, B.K. 1998. Calcium in ischemic cell death. Stroke 29:705‐718.
   Kuribara, H. and Tadukara, S. 1992. Aspects of animal experiments for evaluation of cognitive enhancers: In particular, the behavioural characteristics of Mongolian gerbils. Prog. Neuro‐Psychopharmacol. Biol. Psychiatry 16:389‐396.
   Lees, K.R. 1997. Cerestat and other NMDA antagonists in ischemic stroke. Neurology 49:S66‐S69.
   Levine, S. and Payan, H. 1966. Effects of ischemia and other procedures on the brain and retina of the gerbil. Exp. Neurol. 16:255‐262.
   Loskota, W.J., Lomax, P., and Verity, M.A. 1974. A Stereotaxic Atlas of the Mongolian Gerbil Brain. Ann Arbor Science Publishers, Ann Arbor, Mich.
   Malgouris, C., Bardot, F., Daniel, M., Pellis, F., Rataud, J., Uzan, A., Blanchard, C., and Laduron, P.M. 1989. Riluzole, a novel anti‐glutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils. J. Neurosci 9:3720‐3727.
   McAuley, M.A. 1995. Rodent models of focal ischemia. Cereb. Brain Metab. Rev. 7:153‐180.
   Mileson, B.E. and Schwartz, R.D. 1991. The use of locomotor activity as a behavioural screen for neuronal damage following transient forebrain ischemia in gerbils. Neurosci. Lett 128:71‐76.
   O'Neill, M.J., Earley, B., and Leonard, B.E. 1993. An investigation of ischaemia‐induced behavioural changes in the Mongolian gerbil. J. Psychopharmacol. (suppl.) 88:A25.
   O'Neill, M.J., Canney, M., Earley, B., and Leonard, B.E. 1996. The novel sigma ligand JO1994 protects against ischaemia‐induced behavioural changes, cell death and receptor dysfunction in the gerbil. Neurochem. Int. 28:193‐207.
   O'Neill, M.J., Bond, A., Ornstein, P.L., Ward, M.A., Hicks, C.A., Hoo, K., Bleakman, D., and Lodge, D. 1998. Decahydroisoquinolines: Novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischemia. Neuropharmacology 37:1211‐1222.
   Pettmann, B. and Henderson, C.E. 1998. Neuronal cell death. Neuron 20:633‐647.
   Phebus, L.A. and Clemens, J.A. 1989. Effects of transient, global, cerebral ischemia on striatal extracellular dopamine, serotonin and their metabolites. Life Sci. 44:1335‐1342.
   Pulsinelli, W.A. and Brierley, J.B. 1979. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 10:267‐272.
   Schmidt‐Kastner, R., Paschen, W., Ophoff, B.G., and Hossmann, K.A. 1989. A modified four‐vessel occlusion model for inducing incomplete forebrain ischemia in rats. Stroke 20:938‐946.
   Sheardown, M.J., Nielson, E.O., and Hansen, A.J. 1990. 2,3‐dihydroxy‐6‐nitro‐7‐sulfamonyl‐benzo(F)quinoxaline: A neuroprotectant for cerebral ischemia. Science 247:571‐574.
   Siesjö, B.K. 1992a. Pathophysiology and treatment of focal cerebral ischemia, part I: Pathophysiology. J. Neurosurg. 77:337‐354.
   Siesjö, B.K. 1992b. Pathophysiology and treatment of focal cerebral ischemia, part II: Mechanisms and drug treatment. J. Neurosurg. 77:1247‐1252.
   Thompson, C.B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456‐1462.
   Thornberry, N.A. and Lazebnik, Y. 1998. Caspases: Enemies within. Science 281:1312‐1316.
   Todd, N.V., Picozzi, P., Crockard, A., and Ross, R.R. 1986. Reperfusion after cerebral ischemia: Influence of duration of ischemia. Stroke 17:460‐466.
   Volpe, B.T., Pulsinelli, W.A., Tribuna, J., and Davis, H.P.. 1984. Behavioral performance of rats following transient forebrain ischemia. Stroke 15:558‐562.
Key References
Internet Resources
  http://stroke.ahajournals.org/
  This is the Web site for the journal Stroke (Journal of American Heart Association), which publishes original research papers using animal models, but also publishes clinical papers and updates on current clinical trials in stroke.
  http://cbfm.org/
  This is the Web site of International Society of Cerebral Blood Flow and Metabolism. The official journal of this society is the Journal of Cerebral Blood Flow and Metabolism, which publishes detailed papers using various animal models of cerebral ischemia.
  http://www.ninds.nih.gov/
  This is the Web site for the U.S. NIH, National Institute of Neurological Disorders and Stroke. This government agency also supports basic research through grant funding.
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library